Pharmacodynamics While<unk>  acts at α-adrenergic, dopaminergic, and serotonin receptors (the 5-HT2 receptor), it exerts on the uterus (and other smooth muscles) a powerful stimulant effect not clearly associated with a specific receptor type.<unk>  produces psychedelic effects at high doses (e.g., 2–10 mg; normal therapeutic doses are 0.2 to 0.4 mg). This can be attributed to activation of 5-HT2A receptors.<unk>  is an agonist of the serotonin 5-HT2B receptor and has been associated with cardiac valvulopathy.
Ergometrine
Methylergometrine
Indometacin
Indometacin farnesil
Drostanolone propionate
Xylometazoline
Alclometasone
Norgestimate